[FATE] QoQ Quarter Result on 31-Dec-2015 [#Q4]

Stock
[FATE] Fate Therapeutics, Inc.
Announcement Date
03-Mar-2016
Financial Year
2015
Quarter
31-Dec-2015 [#Q4]
Profit Trend
QoQ- -8.13%
YoY- -19.46%
Quarter Report
FATE's Result
FATE's Financial Summary
View:
Show?
Quarter Result
30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 CAGR
Revenue 1,026 1,027 1,322 1,076 1,026 329 0 -
PBT -8,737 -8,408 -8,377 -7,446 -6,886 -7,779 -7,881 7.09%
Tax 37 31 27 -207 4 2 1 1003.09%
NP -8,737 -8,408 -8,377 -7,446 -6,886 -7,779 -7,881 7.09%
Tax Rate - - - - - - - -
Total Cost 9,763 9,435 9,699 8,522 7,912 8,108 7,881 15.30%
Ratio Analysis
30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 CAGR
NP Margin -851.56 -818.70 -633.66 -692.01 -671.15 -2,364.44 0.00 -
Per Share
30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 CAGR
EPS -0.27 -0.29 -0.29 -0.26 -0.24 -0.33 -0.38 -20.32%
EPS Diluted -0.27 -0.29 -0.29 -0.26 -0.24 -0.33 -0.38 -20.32%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.